Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-64710-6
Affiliations:
11
Authors:
18
Go to article
Institutions Authors Share
Cochin Hospital, France
10.750000
10.750000
 0.60
Paris Cité University, France
1.750000
 0.10
Centre d’Investigation Clinique Vaccinologie Cochin-Pasteur (CIC Cochin-Pasteur), France
1.000000
 0.06
Saint Antoine Research Center (CRSA), France
1.000000
 0.06
National Conservatory of Arts and Crafts (CNAM), France
1.000000
 0.06
HealthFex, France
0.666667
 0.04
Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), France
0.583333
 0.03
Physiopathologie, Cibles et Thérapies de la Polyarthrite Rhumatoïde (Li2P), France
0.500000
 0.03
Hôpital Avicenne, France
0.500000
 0.03
Fédération pour la Recherche sur le Handicap et l'Autonomie (Fedrha), France
0.250000
 0.01
Interested in Medical Biotechnology?